fluorodeoxyglucose f18 has been researched along with Central Nervous System Disease in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 11 (39.29) | 24.3611 |
| 2020's | 5 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, M; Fuwa, M; Ikeda, T; Kanayama, T; Kato, A; Mori, I; Morita, H; Shizui, N; Taguchi, K; Tateyama, S | 1 |
| Booij, J; Brouwer, MC; Fritz, D; van de Beek, D | 1 |
| Kobayashi, M | 1 |
| Chen, G; Chen, X; Fu, Z; Li, Q | 1 |
| Dhanapalaratnam, R; Huynh, W | 1 |
| Erdil, TY; Filizoglu, N; Ones, T; Ozguven, S; Turoglu, HT | 1 |
| Banzo, I; González-Gay, MA; Jiménez-Bonilla, JF | 1 |
| Greib, C; Lazaro, E; Machelart, I; Pellegrin, JL; Rivière, E; Schwartz, P; Viallard, JF | 1 |
| Chen, S; Duan, L | 1 |
| Frohman, LP; Ghesani, N; Khodarahmi, I; Turbin, RE | 1 |
| Chan, M; Hsiao, E | 1 |
| Mottaghy, FM | 1 |
| Altini, C; Asabella, AN; Gatti, P; Iuele, F; Notaristefano, A; Rubini, G | 1 |
| Adams, WM; Bhatnagar, G; Iyengar, S; Maviki, M; Suresh, P; Vardhanabhuti, V; Venkatanarasimha, N | 1 |
| Bartels, S; Blumstein, N; Glöckner, SC; Görg, T; Heckmann, JG; Kyavar, L; Zimmermann, R | 1 |
| Arnold, C; Broadley, SA; Meenakshi, M | 1 |
| Akkas, BE; Vural, GU | 1 |
| Bemstrand, C; Calming, U; Elander, SS; Henter, JI; Ingvar, M; Mosskin, M | 1 |
| Aalto, S; Bergman, J; Hakala, M; Karlsson, H; Kelavuori, JP; Koponen, S; Kurki, T; Niemi, P; Ruotsalainen, U; Stenman, H | 1 |
| Lomeña Caballero, FJ; Simó Perdigó, M | 1 |
| Bairamian, D; Barker, J; Brooks, RA; Di Chiro, G; Kornblith, PL; Mansi, L; Patronas, NJ; Smith, BH | 1 |
| Anayat, AR; Eberl, S; Fulham, MJ; Fulton, RR; Hooper, PK | 1 |
| Shulkin, BL | 1 |
| Beyer, W; Buchert, R; Obrocki, J; Schiemann, T; Thomasius, R; Väterlein, O | 1 |
| Brink, I; Juengling, FD; Kreisel, W; Nitzsche, EU; Otte, A; Peter, HH; Schumacher, M; Weiner, SM | 1 |
| Otte, A; Weiner, SM | 1 |
| Alavi, A; Alavi, J; Chawluk, J; Dann, R; Kushner, M; Reivich, M | 1 |
| Frackowiak, RS; Herold, S; Morgan-Hughes, JA; Petty, RK | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Central Nervous System Disease
| Article | Year |
|---|---|
Extra-pulmonary manifestations of sarcoidosis.
Topics: Cardiomyopathies; Central Nervous System Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Musculoskeletal Diseases; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urologic Diseases | 2012 |
[Indications of PET imaging].
Topics: Cardiovascular Diseases; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
PET applications in pediatrics.
Topics: Central Nervous System Diseases; Child; Child, Preschool; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart Defects, Congenital; Humans; Infant; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Positron emission tomography imaging of regional cerebral glucose metabolism.
Topics: Aging; Brain; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Dementia; Deoxyglucose; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Parkinson Disease; Radiography; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed | 1986 |
24 other study(ies) available for fluorodeoxyglucose f18 and Central Nervous System Disease
| Article | Year |
|---|---|
Neurosarcoidosis pathologically diagnosed via biopsy of a normal-sized inguinal lymph node with fluorodeoxyglucose accumulation on positron emission tomography/computed tomography in a patient with a history of brain Ewing's sarcoma.
Topics: Biopsy; Brain; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Sarcoidosis; Sarcoma, Ewing | 2022 |
Whole-Body 18F-FDG PET-CT in the Diagnosis of Neurosarcoidosis.
Topics: Adult; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2020 |
Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites.
Topics: Asymptomatic Diseases; Biopsy; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Skin Diseases; Subcutaneous Tissue; Whole Body Imaging | 2019 |
18F-FDG PET/CT Findings in a Patient With Neurosarcoidosis.
Topics: Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2020 |
Clinicoradiological dissociation in sarcoid myelopathy.
Topics: Aged; Biopsy; Brain; Central Nervous System Diseases; Eye Pain; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypesthesia; Lymph Nodes; Lymphadenopathy; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Paresthesia; Peripheral Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Cord; Spinal Cord Diseases | 2020 |
Central Nervous System Complications of Erdheim-Chester Disease: FDG PET/CT Findings.
Topics: Central Nervous System Diseases; Erdheim-Chester Disease; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Young Adult | 2021 |
Usefulness of 18F-FDG-PET/CT imaging in a patient with neurosarcoidosis.
Topics: Adult; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2018 |
Neurosarcoidosis and infliximab therapy monitored by 18FDG PET/CT.
Topics: Anti-Inflammatory Agents; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Infliximab; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2019 |
Visual Vignette.
Topics: Adult; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Hypogonadism; Hypothalamic Diseases; Magnetic Resonance Imaging; Male; Pituitary Diseases; Sarcoidosis | 2015 |
18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT.
Topics: Central Nervous System Diseases; Dura Mater; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2016 |
Neurosarcoidosis on FET and FDG PET/CT.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine | 2017 |
Molecular imaging provides a hint that Miller Fisher syndrome might involve the central nervous system.
Topics: Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Miller Fisher Syndrome; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus.
Topics: Adult; Central Nervous System Diseases; Diabetes Insipidus; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
FDG PET findings leading to diagnosis of neurosarcoidosis.
Topics: Adult; Biopsy; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Polyradiculopathy; Positron-Emission Tomography; Sarcoidosis | 2013 |
The value of [18F]-fluorodeoxyglucose-positron emission tomography/CT scanning in the diagnosis of neurosarcoidosis.
Topics: Adult; Central Nervous System; Central Nervous System Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Knee; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Child; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis.
Topics: Adolescent; Adult; Basal Ganglia; Central Nervous System Diseases; Cerebellum; Child; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Hypothalamus; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Severe somatization in women is associated with altered cerebral glucose metabolism.
Topics: Adult; Brain; Central Nervous System Diseases; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Somatoform Disorders; Tomography, Emission-Computed | 2002 |
Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors.
Topics: Animals; Astrocytoma; Blood-Brain Barrier; Brain; Central Nervous System Diseases; Deoxyglucose; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Ischemia; Phosphoric Monoester Hydrolases; Tomography, Emission-Computed | 1984 |
Evaluation of two population-based input functions for quantitative neurological FDG PET studies.
Topics: Adult; Autoradiography; Blood Specimen Collection; Brain; Central Nervous System Diseases; Deoxyglucose; Diabetic Neuropathies; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Regression Analysis; Tomography, Emission-Computed | 1997 |
Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography.
Topics: Adult; Case-Control Studies; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Glucose; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Tomography, Emission-Computed | 1999 |
Neuro-Behçet's syndrome in a patient not fulfilling criteria for Behçet's disease: clinical features and value of brain imaging.
Topics: Adult; Behcet Syndrome; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Systemic lupus erythematosus.
Topics: Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases.
Topics: Adult; Brain; Brain Diseases; Central Nervous System Diseases; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Metabolism, Inborn Errors; Middle Aged; Mitochondria, Muscle; Oxygen Consumption; Reference Values; Tomography, Emission-Computed | 1988 |